“…Loganin significantly upregulated postsynaptic density-95 (PSD95), synaptophysin (SYP), Mfn2, and OPA1 protein levels in the hippocampus of 3×Tg-alzheimer disease (AD) mice, downregulated Drp1, Fis1, LC3II, p62, PINK1, Parkin, TOMM20, and COX isoform IV expression, improved amyloid β-protein (Aβ) deposition and synaptic ultrastructure in 3×Tg-AD mice, restored mitochondrial fission/fusion homeostasis, alleviated the abnormal degradation of mitophagy, and restored the learning and memory ability of 3×Tg-AD mice. In vitro experiments further confirmed that Loganin significantly upregulated OPTN expression and downregulated LC3II, p62, PINK1, and Parkin protein expression in Aβ 25-35 -treated human neuroblastoma cells (SK-N-SH), and significantly ameliorated mitochondrial dysfunction, whereas OPTN silencing counteracted the restoration of mitochondrial function by Loganin, confirming that Loganin may improve cognitive function in AD mice by promoting OPTN-mediated mitophagy ( Zhou Y. et al, 2023 ). Melatonin, an endogenous circadian indoleamine secreted by the pineal gland, has a wide range of biological functions, including antioxidant, anti-inflammatory, antitumor, and neuroprotective effects ( Porfirio et al, 2017 ).…”